- Home
- Publications
- Publication Search
- Publication Details
Title
Idelalisib
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 49, Issue 10, Pages 1162-1170
Publisher
SAGE Publications
Online
2015-07-17
DOI
10.1177/1060028015594813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin’s lymphoma
- (2015) Gillian M. Keating Targeted Oncology
- How will B-cell-receptor-targeted therapies change future CLL therapy?
- (2014) J. A. Jones et al. BLOOD
- High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
- (2014) N. A. Brown et al. BLOOD
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment Paradigms
- (2014) F. T. Awan et al. CLINICAL CANCER RESEARCH
- Idelalisib: First Global Approval
- (2014) Anthony Markham DRUGS
- Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician
- (2014) John C. Byrd et al. JOURNAL OF CLINICAL ONCOLOGY
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia
- (2014) Clement Chung et al. PHARMACOTHERAPY
- Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
- (2014) Antonio Cuneo et al. Cancer Medicine
- Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia—Focus on the B-Cell Receptor
- (2013) Elisa ten Hacken et al. CLINICAL CANCER RESEARCH
- Targeted Therapy in Chronic Lymphocytic Leukemia: Past, Present, and Future
- (2013) Alexey V. Danilov CLINICAL THERAPEUTICS
- Targeting pathological B cell receptor signalling in lymphoid malignancies
- (2013) Ryan M. Young et al. NATURE REVIEWS DRUG DISCOVERY
- A Mechanism-Driven Treatment for Chronic Lymphocytic Leukemia?
- (2013) Robin Foà et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Monoclonal antibody therapy of chronic lymphocytic leukaemia
- (2010) Bruce D. Cheson BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now